Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Latest Articles

  • You have access
    Cancer-derived Exosomes Activate Immune Surveillance and Suppress Peritoneal Metastasis of Murine Colonic Cancer
    AYA TOKUDA, TORU MIYAKE, DAIKI YASUKAWA, DAIJI IKUTA, KEN-ICHI MUKAISHO, SATOSHI MURATA, TOMOHARU SHIMIZU and MASAJI TANI
    Anticancer Research March 2021, 41 (3) 1327-1339; DOI: https://doi.org/10.21873/anticanres.14890
  • You have access
    Neutrophil-to-lymphocyte Ratio as a Predictor of Malignancy of Intraductal Papillary Mucinous Neoplasms
    KEISHI SUGIMACHI, YOHEI MANO, YOSHIHIRO MATSUMOTO, TOMONORI NAKANOKO, HIDEO UEHARA, YUICHIRO NAKASHIMA, MASAHIKO SUGIYAMA, MITSUHIKO OTA, MASARU MORITA and YASUSHI TOH
    Anticancer Research March 2021, 41 (3) 1663-1669; DOI: https://doi.org/10.21873/anticanres.14929
  • You have access
    T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies
    KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES
    Anticancer Research March 2021, 41 (3) 1143-1156; DOI: https://doi.org/10.21873/anticanres.14871
  • You have access
    Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy
    SATORU FURUHASHI, YOSHIFUMI MORITA, SHINYA IDA, RYUTA MURAKI, RYO KITAJIMA, KATSUNORI SUZUKI, MAKOTO TAKEDA, HIROTOSHI KIKUCHI, YOSHIHIRO HIRAMATSU, KIYOTAKA KURACHI, YOJI SHIDO, KEN SUGIMOTO, HIROAKI ITO, YUICHIRO MAEKAWA, HIROYUKI MINETA, HIDEAKI MIYAKE and HIROYA TAKEUCHI
    Anticancer Research March 2021, 41 (3) 1547-1553; DOI: https://doi.org/10.21873/anticanres.14914
  • You have access
    Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated ApcMin/+ Mice
    MASARU TERASAKI, TAKAHIRO HAMOYA, ATSUHITO KUBOTA, HIROYUKI KOJIMA, TAKUJI TANAKA, HAYATO MAEDA, KAZUO MIYASHITA and MICHIHIRO MUTOH
    Anticancer Research March 2021, 41 (3) 1299-1305; DOI: https://doi.org/10.21873/anticanres.14887
  • You have access
    Amentoflavone Induces Cell-cycle Arrest, Apoptosis, and Invasion Inhibition in Non-small Cell Lung Cancer Cells
    WEI-TING CHEN, CHENG-HSIEN CHEN, HUNG-TAI SU, PO-FU YUEH, FEI-TING HSU and I-TSANG CHIANG
    Anticancer Research March 2021, 41 (3) 1357-1364; DOI: https://doi.org/10.21873/anticanres.14893
  • You have access
    Staged Stereotactic Radiosurgery Decreases Symptomatic Radionecrosis in Large Brain Metastasis
    NEIL CHEVLI, HUI-CHUAN WANG, PRACHI DUBEY, WAQAR HAQUE, ANDREW M. FARACH, RAMIRO PINO, ROBERT C. ROSTOMILY, E. BRIAN BUTLER and BIN S. TEH
    Anticancer Research March 2021, 41 (3) 1445-1449; DOI: https://doi.org/10.21873/anticanres.14902
  • You have access
    Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases
    CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA
    Anticancer Research March 2021, 41 (3) 1471-1474; DOI: https://doi.org/10.21873/anticanres.14905
  • You have access
    Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma
    YOSHIFUMI KADONO, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, TAIKI KAMIJIMA, CHIKASHI SETO, AKINOBU TAKANO, SATOSHI YOTSUYANAGI, RYUNOSUKE NAKAGAWA, TOHRU MIYAGI, SHUHEI AOYAMA, HIDEKI ASAHI, RIE FUKUDA and ATSUSHI MIZOKAMI
    Anticancer Research March 2021, 41 (3) 1599-1606; DOI: https://doi.org/10.21873/anticanres.14921
  • You have access
    MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53
    XIAOCHEN ZHANG, YOSHIYUKI YAMAMOTO, XIAOXUAN WANG, MASASHI SATO, MAMIKO IMANISHI, AKINORI SUGAYA, MITSUAKI HIROSE, SHINJI ENDO, TOSHIKAZU MORIWAKI, KENJI YAMATO and ICHINOSUKE HYODO
    Anticancer Research March 2021, 41 (3) 1475-1483; DOI: https://doi.org/10.21873/anticanres.14906

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 1462
Anticancer Research

© 2021 Anticancer Research

Powered by HighWire